Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
290 GBX | -4.61% | +7.41% | +2.47% |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Neutral |
Resistance | 304.00 | 326.00 | 321.00 |
Spread/Res. | -4.61% | -11.04% | -9.66% |
Spread/Supp. | +2.84% | +50.73% | +67.05% |
Support | 282.00 | 192.40 | 173.60 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- HCM Stock
- Charts HUTCHMED (China) Limited